2022 · Translational and clinical pharmacology · open access
Stability of acetylsalicylic acid in human blood collected using volumetric absorptive microsampling (VAMS) under various drying conditions
Moon et al.
The finding, in our words
The study found that acetylsalicylic acid recovered poorly from VAMS blood samples dried at room temperature, reaching only about 31% of the concentration measured in venous control samples, but humidity-controlled drying raised recovery above 85%. A household vacuum sealer achieved adequate humidity control at home, supporting the feasibility of decentralised, patient-centric blood sampling for acetylsalicylic acid monitoring.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
In 55 patients, four approaches to convert dried capillary blood concentrations to plasma equivalents were evaluated. All methods except haematocrit-based conversion yielded acceptable analytical and clinical agreement for paracetamol and metabolites, supporting the reliability of capillary microsampling for decentralised therapeutic drug monitoring.
Boffel et al., The AAPS journal (paywalled) · source ↗
The authors developed and validated a workflow that couples Mitra volumetric absorptive microsampling with hybridisation LC-MS/MS to quantify the antisense oligonucleotide fomivirsen in human blood. Quantitative recovery was achieved irrespective of haematocrit level or sample age, and the method demonstrated sensitivity, linearity, precision, accuracy, and four-month stability, supporting its use for therapeutic drug monitoring of biologic candidates in decentralised trials.
The study found that blood concentrations of padsevonil measured using Mitra devices can reliably predict plasma concentrations with less than 9% mean bias, supporting the use of VAMS as a patient-centric alternative to venous sampling in decentralised trials. This validation strengthens confidence in microsampling for therapeutic drug monitoring where venous draws are impractical.
Kramer et al., The AAPS journal (paywalled) · source ↗
The study validated a sensitive LC-MS/MS method to measure rosuvastatin in 10 µL of blood collected using VAMS, with acceptable accuracy and precision across multiple days. Rosuvastatin remained stable in VAMS samples for 10 days at room temperature without pH buffer, supporting its use in decentralised clinical trials and patient-centric therapeutic drug monitoring.
Moon et al., Translational and clinical pharmacology · source ↗
The study validated a VAMS-based bioanalytical method using the Tasso OnDemand device for the drug gefapixant and demonstrated a mathematical bridging relationship with standard plasma assays, supporting its use in decentralised clinical trials.
Roadcap et al., Bioanalysis (paywalled) · source ↗